miR-124-3p was demonstrated to inhibit the PD-L1 pathway and STAT3 signaling in CRC, which might indicate that miR-124-3p mediated the MDSCs of CRC through the PD-L1/STAT3 pathway (36). The gene discussed is STAT3; the disease is colorectal carcinoma.